about
Prognostic significance of smac/DIABLO in endometrioid endometrial cancerPotential application of curcumin and its analogues in the treatment strategy of patients with primary epithelial ovarian cancer.Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma.Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses.Transvaginal electrical stimulation with surface-EMG biofeedback in managing stress urinary incontinence in women of premenopausal age: a double-blind, placebo-controlled, randomized clinical trialSerum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer.Quality of life in long-term survivors of early stage endometrial cancer.Utility of HE4 to identify patients with endometrioid endometrial cancer who may require lymphadenectomy.Circulating free DNA and p53 antibodies in plasma of patients with ovarian epithelial cancersSerum levels of VEGF and VEGF-C in patients with endometrial cancerTumor necrosis factor-alpha and its receptors in epithelial ovarian cancerCirculating levels of TNF-alpha and its soluble receptors in the plasma of patients with epithelial ovarian cancerCirculating free DNA, p53 antibody and mutations of KRAS gene in endometrial cancerMutations in the KRAS gene in ovarian tumorsPretreatment serum levels of bFGF and VEGF and its clinical significance in endometrial carcinoma
P50
Q28308297-C47C0B77-CFE9-4398-AC25-F17ACA6EA164Q34833628-08FF1278-7299-4C8C-963B-1C6105571C98Q35929423-1BB37724-A9BF-43AD-9D90-799A8B4607D6Q37111350-7688428E-76A2-4D5F-B1B2-C74B5EEF95D6Q37188246-68B82A8D-5154-4F83-B32E-87A3BC41074FQ45283850-67B74F98-790B-4BED-9A71-06FC923AE794Q47550522-0D9536CF-139C-4BF8-8999-9261777DEC85Q53354618-27DA6549-169B-41EA-89A5-1323DF26361CQ82562900-34B50CCB-5F5C-4309-8C06-DBF38D91968AQ83630843-9C82BF93-B04F-409D-A90E-022BE9812FAFQ84133426-DE2E7F3B-FD00-43C4-A21C-DC9F5901A424Q84713742-DEF2B697-0612-4FD9-B932-C5066E6EA68EQ84978415-D36D4137-7763-4B18-8F81-5EE4A02C045EQ85054904-B7DDB1CA-3B05-4923-B459-D5DD405A6D18Q85598108-0AACB735-E964-45CB-AAF1-0DA36EF8AEDF
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
B Dobrzycka
@en
B Dobrzycka
@nl
type
label
B Dobrzycka
@en
B Dobrzycka
@nl
prefLabel
B Dobrzycka
@en
B Dobrzycka
@nl
P31
P496
0000-0001-8992-707X